Literature DB >> 11709525

Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.

K W Burak1, S S Lee, P L Beck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709525      PMCID: PMC1728555          DOI: 10.1136/gut.49.6.866

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  94 in total

1.  Successful control of bleeding from gastric antral vascular ectasia (watermelon stomach) by laser photocoagulation.

Authors:  H H Tsai; J Smith; B J Danesh
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

2.  Frequency and factors influencing portal hypertensive gastropathy and duodenopathy in cirrhotic portal hypertension.

Authors:  R Gupta; V A Saraswat; M Kumar; S R Naik; R Pandey
Journal:  J Gastroenterol Hepatol       Date:  1996-08       Impact factor: 4.029

Review 3.  Gastric antral vascular ectasia: a case report and review of the literature.

Authors:  B E Herman; J J Vargo; S Baum; E D Silverman; J Eisold
Journal:  J Nucl Med       Date:  1996-05       Impact factor: 10.057

4.  Rebamipide prevents occurrence of gastric lesions following transcatheter arterial embolization in the hepatic artery.

Authors:  H Nomura; K Miyake; R Hirakata; S Migita; O Okamoto; G Shiraishi
Journal:  J Gastroenterol Hepatol       Date:  1999-05       Impact factor: 4.029

5.  Helicobacter pylori and congestive gastropathy.

Authors:  A Bahnacy; P Kupcsulik; Z S Elés; B Jàray; L Flautner
Journal:  Z Gastroenterol       Date:  1997-02       Impact factor: 2.000

6.  Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis.

Authors:  P S Kamath; M Lacerda; D A Ahlquist; M A McKusick; J C Andrews; D A Nagorney
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

7.  Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study.

Authors:  A Tran; J P Villeneuve; M Bilodeau; B Willems; D Marleau; D Fenyves; R Parent; G Pomier-Layrargues
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

8.  Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension.

Authors:  S K Sarin; D V Sreenivas; D Lahoti; A Saraya
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

9.  Chronic administration of octreotide ameliorates portal hypertension and portal hypertensive gastropathy in rats with cirrhosis.

Authors:  C C Chan; F Y Lee; S S Wang; F Y Chang; H C Lin; H J Lin; C J Chu; S L Wu; C C Tai; S D Lee
Journal:  Clin Sci (Lond)       Date:  1998-04       Impact factor: 6.124

10.  Effects on gastric circulation of treatment for portal hypertension in cirrhosis.

Authors:  S Sezai; M Ito; Y Sakurai; K Kamisaka; T Abe; F Ikegami; Y Yamamoto; M Hirano
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

View more
  26 in total

1.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

2.  Severe hemorrhage from gastric vascular ectasia developed in a patient with AML.

Authors:  Tohru Takahashi; Takuya Miya; Mariko Oki; Nobuaki Sugawara; Mitsuru Yoshimoto; Masayuki Tsujisaki
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

Review 3.  Approach to the management of portal hypertensive gastropathy and gastric antral vascular ectasia.

Authors:  Bezawit D Tekola; Stephen Caldwell
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-11-09

4.  Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial.

Authors:  Emily W Hung; Maureen D Mayes; Roozbeh Sharif; Shervin Assassi; Victor I Machicao; Chitra Hosing; E William St Clair; Daniel E Furst; Dinesh Khanna; Stephen Forman; Shin Mineishi; Kristine Phillips; James R Seibold; Christopher Bredeson; Mary Ellen Csuka; Richard A Nash; Mark H Wener; Robert Simms; Karen Ballen; Sharon Leclercq; Jan Storek; Ellen Goldmuntz; Beverly Welch; Lynette Keyes-Elstein; Sharon Castina; Leslie J Crofford; Peter Mcsweeney; Keith M Sullivan
Journal:  J Rheumatol       Date:  2013-02-15       Impact factor: 4.666

5.  Randomized controlled study of endoscopic band ligation and argon plasma coagulation in the treatment of gastric antral and fundal vascular ectasia.

Authors:  Mohammed Elhendawy; Samah Mosaad; Walaa Alkhalawany; Lobna Abo-Ali; Mohamed Enaba; Aymen Elsaka; Asem A Elfert
Journal:  United European Gastroenterol J       Date:  2015-12-15       Impact factor: 4.623

6.  Laser therapy and surgical treatment in transfusion-dependent patients with upper-gastrointestinal vascular ectasia.

Authors:  Lino Polese; Imerio Angriman; Duilio Pagano; Maria L Tenderini; Francesca Polese; Mauro Frego; Davide F D'Amico; Lorenzo Norberto
Journal:  Lasers Med Sci       Date:  2006-07-29       Impact factor: 3.161

7.  Gastric antral vascular ectasia (GAVE) in a non-cirrhotic patients with diabetes: case report and possible pathophysiological mechanism.

Authors:  Abdul Majid Wani; Waleed Mohd Hussain; Abdulhakeem Banjar; Wail H Almaimani; Jamal Talaat Hamdi; Khalid J Hamdi; Amer Mohd Khoujah; Mubeena Akhtar
Journal:  BMJ Case Rep       Date:  2010-04-29

Review 8.  Management of gastropathy and gastric vascular ectasia in portal hypertension.

Authors:  Cristina Ripoll; Guadalupe Garcia-Tsao
Journal:  Clin Liver Dis       Date:  2010-05       Impact factor: 6.126

Review 9.  Update of endoscopy in liver disease: more than just treating varices.

Authors:  Christoforos Krystallis; Gail S Masterton; Peter C Hayes; John N Plevris
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

Review 10.  Watermelon stomach: pathophysiology, diagnosis, and management.

Authors:  Yuri W Novitsky; Kent W Kercher; Donald R Czerniach; Demetrius E M Litwin
Journal:  J Gastrointest Surg       Date:  2003 Jul-Aug       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.